Dr. Roberto Pecoits-Filho is currently a Senior Research Scientist, Arbor Research Collaborative for Health in the USA and a full professor at the School of Medicine, Catholic University of Paraná, where he was the director of the PhD and Masters Programs in Health Sciences, Chief of Nephrology and co-founder of the Academic Clinical Research Organization (ACRO) EPICENTER (Center of Epidemiology and Clinical Research) and PUCTrials in the same institution. Dr. Pecoits-Filho received his M.D. degree in 1993, trained in Internal Medicine and Nephrology in Curitiba and completed his nephrology fellowship at the University of Missouri, Columbia in 1997-98. He received a Ph.D. from the University of São Paulo and thereafter went to Sweden as a visiting scholar at the Karolinska Institutet from 1999 to 2002. Dr. Pecoits-Filho was a visiting fellow at the George Institute in Sydney in 2017.
Dr. Pecoits-Filho has been involved in clinical research since 2003, and was a principal investigator of 17 multicentric clinical trials. He is a National Leader of several ongoing clinical trials such as Credence, Olympus, and CKD DAPA and sits at the steering committee of the observational studies CKDOPPS, MONDO and BRAZPD. He was the Chair of the Steering Committee of the STARCH, SALTED and HDFit multicentric trials in Brazil that were coordinated by the ACRO PUCTrials. In those trials, he played an active role in study design, implementation, coordination, event adjudication, data management and led the data monitoring safety board (DMSB) for STARCH and HDFit.
Dr. Pecoits-Filho is part of the Editorial Board of American Journal of Kidney Diseases, Peritoneal Dialysis International, and Blood Purification. During his career, he has published his research in over 240 papers in international indexed journals, and lectured in more than 40 countries around the world.
In the past he was scientific director of the Brazilian Society of Nephrology and vice president of the Latin American Society of Nephrology and Hypertension. He was awarded the Young Nephrology Leader Award of the Global Kidney Academy, the Maher Award of the ISPD, Paraná State Award for Science and Technology and was an Education Ambassador of the ISN. Currently, he is a Councilor of the International Society of Nephrology. He is also a member of the Executive Committee of KDIGO and part of the Core Group of ISN’s Advancing Clinical Trials (ACT) Initiative, and the International Network of Chronic Kidney Disease Cohort Studies (iNET-CKD).